Omec.ai
OM
About
Omec.ai leverages artificial intelligence and machine learning to enhance the efficiency and success rates of drug discovery and development processes. Their platform aims to help pharmaceutical and biotech companies identify novel drug candidates, optimize preclinical studies, and accelerate clinical trials.
Key facts
At-a-glance profile data
- Website
- omec.ai
- Headquarters
- Boston, United States
- Founded
- 2022
- Total funding
- $12M (Seed)
- Business model
- B2B
Funding rounds
Add first review
Frequently asked
How much funding has Omec.ai raised?
Omec.ai has raised a total of $12M in funding. The most recent round on record is Seed.
What is Omec.ai's current status?
Omec.ai's current operating status is: Inactive.